Dr. Sebastian Salvatore Demarco, MD

Dr. Demarco practices at Advanced Dermatology of Virginia Inc in Maitland, Florida.

Dr. Demarco's NPI, 1063807980, was assigned on March 30, 2015. Dr. Demarco graduated from Brody School Of Medicine At East Carolina University in 2015. Dr. Demarco's New York license number on file is 289340.

Dr. Demarco's primary practice is Advanced Dermatology of Virginia Inc, at 151 Southhall Ln, Maitland, FL 32751 in Orange County. The practice phone is (703) 370-0073.

Dr. Demarco's primary practice is Advanced Dermatology of Virginia Inc in Maitland, Florida. The medical group on file is Advanced Dermatology and Cosmetic Surgery. Dmand AI also links Dr. Demarco to 5 more group practices and clinics and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Demarco practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Demarco's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Demarco is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Demarco's licenses on file in 6 states: New York, District of Columbia, Maryland, Pennsylvania, Virginia and New Jersey.

Dmand AI lists cancerous skin growth removal among the conditions Dr. Demarco treats.

CMS data shows 1,743 Medicare services from Dr. Demarco across 22 procedure codes in 2024, for 491 Medicare patients. Medicare paid $507,268 for them. Every service was in an office.

CMS counts 491 Medicare patients who saw Dr. Demarco in 2024. The largest group is 75 to 84, with 218 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Demarco's median patient age at 62, with 47% women.

In 2024, Dr. Demarco wrote 143 Medicare Part D claims for 106 patients. 96% of them were for generic drugs. CMS names the drug for 90 of them, across 4 drugs with 11 or more claims each, at $1,881 in total drug cost. In 2023, CMS named 112 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Demarco for performance year 2024, reported as part of a group. Dr. Demarco accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 189 procedures of melanoma (skin cancer) excision by Dr. Demarco, more than 97% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Demarco, published from 2014 to 2016. 2015 was the busiest year, with 2. The most frequent topics are Skin Neoplasms. Dr. Demarco's most frequent co-authors are Natalie L. Davis, MD, Jennifer L. Defazio, MD and Charles M. Phillips, MD.

CMS Open Payments shows 110 general payments to Dr. Demarco from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Incyte Corporation paid the most, $665.

Dr. Demarco graduated from Brody School Of Medicine At East Carolina University in 2015. Dr. Demarco is a member of AOA, AAD and ASDS.

Dr. Demarco is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.